Huawei has laid off more than 600 workers from its US-based research arm Futurewei, as a result of being put on a trade blacklist by the US government
SANTA CLARA, Calif./HONG KONG (Reuters) - China's Huawei Technologies laid off more than two-thirds of the 850-strong workforce …
Context & Ripple Effects
The layoffs confirm a retreat that had been telegraphed for months: in January the Commerce Department signaled it would not renew Futurewei's export license (Commerce Department signals it will not renew Futurewei's export license), and by June the Silicon Valley R&D unit was already trying to wall off its operations from its parent while staying owned by Huawei (Futurewei moved to separate its operations from Huawei). Now more than two-thirds of the roughly 850-person workforce is out.
It is also the second act of a longer unwind — back in 2018 Huawei had already laid off its US-based employees and dialed back political outreach as its push into the American market stalled (Huawei's 2018 US pullback and outreach cuts). What remains of Futurewei after this round is a research arm with little legal room to move technology across the border.
First-order effects
- More than 600 of Futurewei's roughly 850 US-based researchers lose their jobs, and Huawei loses most of its onshore R&D capacity in Silicon Valley and its other American labs.
- The June restructuring attempt — separating operations while keeping ownership — did not save the unit, leaving Huawei with no compliant way to run US research under the blacklist.
Second-order effects
- The displaced researchers become hiring stock for rival US semiconductor and cloud firms, transferring Huawei-funded expertise directly into American competitors' labs.
- With its US research and political-outreach channels gone, Huawei's remaining American presence shifts from engagement to damage control, hardening the case inside China for building R&D and components at home.
Third-order effects
- If the pattern holds, blacklisting stops being a sales barrier and becomes an R&D-decoupling tool: Washington tightened the screws again in August 2020 by restricting Huawei's semiconductor access and adding affiliates in 21 countries to the blacklist (US tightens Huawei semiconductor restrictions), while Beijing responds by forcing chipmakers toward domestically made equipment.
- Cross-border corporate R&D labs — long the quiet glue of US-China tech interdependence — become structurally untenable whenever either government can sever them with a list designation.
The trend: US-China tech conflict is dismantling cross-border R&D footprints, converting shared research labs into the first casualties of export-control escalation.